CIK: 0001634557
申报总市值
—
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABBV | Abbvie INC | 股票-医疗保健 | 29.45% | — | -2.81% | |
| 2 | PRTA | Prothena Corporation plc | 股票-其他 | 25.64% | — | +7.72% | |
| 3 | ALKS | Alkermes plc | 股票-医疗保健 | 18.09% | — | +0.26% | |
| 4 | TBPH | Theravance Biopharma, Inc. | 股票-其他 | 16.31% | -71.30% | EXIT | |
| 5 | GILD | Gilead Sciences INC | 股票-医疗保健 | 4.47% | — | +158.52% | |
| 6 | BIIB | Biogen INC | 股票-医疗保健 | 4.26% | — | +51.61% | |
| 7 | ✓ | Bioverativ Inc | 股票-其他 | 1.78% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | GILD | Gilead Sciences INC | +2.4% | +158.52% | 加仓 |
| 2 | PRTA | Prothena Corporation plc | +1.2% | +7.72% | 加仓 |
| 3 | BIIB | Biogen INC | +1.1% | +51.61% | 加仓 |
| 4 | TBPH | Theravance Biopharma, Inc. | +0.2% | +1.88% | 加仓 |
| 5 | ALKS | Alkermes plc | -1.9% | +0.26% | 加仓 |
| 6 | ABBV | Abbvie INC | -4.4% | -2.81% | 减仓 |
| 7 | ✓ | Bioverativ Inc | — | NEW | 新建仓 |
| 8 | NWBO | Northwest Biotherapeutics | — | EXIT | 清仓 |